| # | Status | Study Title |
| 1 | Not yet recruiting | Staging and Prognosis of Deep Venous Thrombosis of Lower Extremities |
| 2 | Recruiting | Prospective Epidemiological Study of Upper Limb Venous Thrombosis |
| 3 | Recruiting | Study of Rivaroxaban for CeREbral Venous Thrombosis |
| 4 | Not yet recruiting | Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis |
| 5 | Recruiting | Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology |
| 6 | Recruiting | Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis |
| 7 | Recruiting | Diagnostic Validity of [18F]GP1 PET for Diagnosing Acute Deep Vein Thrombosis |
| 8 | Not yet recruiting | Targeted Metabolic Profiling in Deep Vein Thrombosis |
| 9 | Active, not recruiting | Prospective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics Patients |
| 10 | Recruiting | Catheter-directed Thrombolysis Compared to Anticoagulation Alone for Acute Primary Iliofemoral Deep Venous Thrombosis |
| 11 | Active, not recruiting | The Designer D-dimer Deep Vein Thrombosis Diagnosis (4D) Study |
| 12 | Recruiting | Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU |
| 13 | Recruiting | Doppler Ultrasound Imaging of Plastic Surgery Patients for DVT Detection |
| 14 | Not yet recruiting | Cerebral Venous Thrombosis Cohort Study in China Mainland |
| 15 | Recruiting | Diagnosis Exclusion of Recurrent Deep Vein Thrombosis of the Lower Limbs |
| 16 | Active, not recruiting | Osteopathic Treatment and Deep Vein Thrombosis (DVT) |
| 17 | Recruiting | Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis |
| 18 | Recruiting | Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study |
| 19 | Recruiting | Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis |
| 20 | Recruiting | Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis |
| 21 | Recruiting | Clinical Course of Cirrhotic Patients With Portal Vein Thrombosis Treated With TIPS |
| 22 | Recruiting | D-dimer and Pre-test Clinical Probability Score in Cancer Patients With Suspected Deep Vein Thrombosis of the Legs |
| 23 | Recruiting | Exercise Intolerance and Skeletal Muscle Bioenergetics in Children With Deep Venous Thrombosis |
| 24 | Recruiting | Resolution Enhancement by a Supplemental Obstruction Lessening Venoactive Drug for Eight Weeks in Deep Vein Thrombosis |
| 25 | Recruiting | Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer |
| 26 | Recruiting | Contemporary Endovascular Therapies in Treatment of Acute Iliofemoral Deep Vein Thrombosis |
| 27 | Recruiting | Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis |
| 28 | Recruiting | Risk of Recurrent Venous Thromboembolism After Provoked Venous Thromboembolism |
| 29 | Recruiting | Retrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter |
| 30 | Not yet recruiting | Phase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 Tablets in Chinese Healthy Volunteers |
| 31 | Active, not recruiting | Patient Education Bundle vs. Nurses Feedback and Coaching to Prevent Missed Doses of VTE Prophylaxis |
| 32 | Recruiting | Ongoing Registry of Deep Venous Reconstructions |
| 33 | Recruiting | TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis |
| 34 | Recruiting | Whole-leg Ultrasound in Pregnant Patients |
| 35 | Active, not recruiting | Evaluation of the Duration of Therapy for Thrombosis in Children |
| 36 | Recruiting | Generation of Thrombin and Prediction of Deep Vein Thrombosis Post Prosthetic Orthopedic Surgery of the Lower Limbs |
| 37 | Recruiting | FUVID Study: Functional Characterization of Children With Chronic Venous Thromboembolic Disease |
| 38 | Active, not recruiting | Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosis |
| 39 | Recruiting | Non-elastic Compression Garment Therapy Versus Control for Deep Vein Thrombosis |
| 40 | Recruiting | Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis |
| 41 | Recruiting | The Incidence of Perioperative Deep Venous Thromboses of the Lower Extremities |
| 42 | Recruiting | Real World Study of Deep Venous Thrombosis. Analysis of Prospective Cases in University Hospitals of São Paulo |
| 43 | Recruiting | Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait |
| 44 | Active, not recruiting | Outcomes in Patients With Myeloproliferative Neoplasm and Splanchnic Vein Thrombosis |
| 45 | Not yet recruiting | Acute Pancreatitis and Thrombosis (PATHRO) |
| 46 | Recruiting | Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy. A Cohort Study. |
| 17 | Recruiting | Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial) |
| 48 | Recruiting | Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy |
| 49 | Active, not recruiting | Geko Neuromuscular Stimulator vs Thromboembolism Deterrent Stockings (TEDS): DVT Prevention Study |
| 50 | Recruiting | Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT） |
| 51 | Recruiting | Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS |
| 52 | Active, not recruiting | Epidemiology of Venous Thrombosis and Pulmonary Embolism |
| 53 | Not yet recruiting | Construction and External Validation of a Predictive Clinico-biological Score of the Risk of Venous Thrombosis in Women Under Combined Oral Contraceptives |
| 54 | Recruiting | Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban |
| 55 | Recruiting | A Study of the IJV or the SCV Approach for Ultrasound-guided Implantation of TIVAD |
| 56 | Recruiting | DOAC in Unusual Site Venous Thrombosis |
| 57 | Recruiting | Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy |
| 58 | Active, not recruiting | The Venous Thrombus Extraction (VETEX) Clinical Study: A Preliminary Investigation |
| 59 | Recruiting | Safety and Efficacy of Thrombolysis in Combination With Endhole Aspiration in the Treatment of Acute DVT |
| 60 | Recruiting | Reliability of Duplex Ultrasound for Diagnosis of Deep Vein Thrombosis Performed by Nurses |
| 61 | Recruiting | Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis |
| 62 | Active, not recruiting | ADAMTS-13 LEVEL AS PREDICTIVE BIOMARKER FOR DEVELOPMENT OF PORTAL VEIN THROMBOSIS IN LIVER CIRRHOSIS (ADAPTHRO) |
| 63 | Recruiting | Comparison of the Effects of Lower Limb Immobilisation With Cast and Orthosis |
| 64 | Active, not recruiting | Early Mobilization After Achilles Tendon Rupture |
| 65 | Active, not recruiting | Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis |
| 66 | Recruiting | Six Years of Follow-up After Idiopathic Venous Throbmoembolism |
| 67 | Recruiting | Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement |
| 68 | Recruiting | Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients |
| 69 | Active, not recruiting | Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome |
| 70 | Recruiting | Novel PET/CT and Treatment Strategies to Reduce PTS Following DVT |
| 71 | Enrolling by invitation | The DARE Warfarin CER Study |
| 72 | Recruiting | Risk Prediction of Venous Thromboembolism in Critically Ill |
| 73 | Recruiting | Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression – The PLICTS Study |
| 74 | Recruiting | PeriOperative ISchemic Evaluation-3 Trial |
| 75 | Recruiting | Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer |
| 76 | Recruiting | Deep Venous Thrombus Characteristics and Venous Dynamics With Subsequent Thrombus Resolution and Post-thrombotic Syndrome |
| 77 | Not yet recruiting | Compression Hosiery to Avoid Post-Thrombotic Syndrome |
| 78 | Recruiting | Prophylactic Anticoagulation for Catheter-related Thrombosis |
| 79 | Recruiting | Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE |
| 80 | Recruiting | Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 |
| 81 | Recruiting | Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study |
| 82 | Enrolling by invitation | Effects of External Leg Compression Devices on Healing and Blood Clotting |
| 83 | Active, not recruiting | Fearon Algorithm in Warfarin Patient Self-Management |
| 84 | Recruiting | Registry of Patients Prescribed Anticoagulation |
| 85 | Recruiting | 3D-biomodels for Surgical Planning in Patients With Renal Cancer and Vascular Involvement |
| 86 | Recruiting | Role of EUS Guided FNA of Portal Vein Thrombus in the Diagnosis and Staging of Hepatocellular Carcinoma |
| 87 | Recruiting | Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study |
| 88 | Recruiting | Chances in Portal System Flow After Two Bariatric Procedures |
| 89 | Not yet recruiting | Mexican Multidisciplinary Registry of Patients With Venous Thromboembolic Disease |
| 90 | Recruiting | The China Pulmonary Thromboembolism Registry Study |
| 91 | Not yet recruiting | Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome |
| 92 | Not yet recruiting | Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting |
| 93 | Recruiting | Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19 |
| 94 | Not yet recruiting | CHIPs-VTE Study in Hospitalized Patients With Lung Cancer |
| 95 | Recruiting | ThRombosis ExclUsion STudy |
| 96 | Recruiting | Post-Market Clinical Follow-up Study With ASPIREX®S to Assess the Safety and Effectiveness in the Treatment of DVT |
| 97 | Enrolling by invitation | ClotTriever Outcomes (CLOUT) Registry |
| 98 | Recruiting | Long Term Outcomes of Venous Thromboembolism |
| 99 | Recruiting | Association Between Genetic Variant Scores and Warfarin Effect |
| 100 | Recruiting | Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System |
| 101 | Recruiting | Swiss Liver Venous Thrombosis Study |
| 102 | Recruiting | SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT |
| 103 | Recruiting | Neo-TACE-HAIC for PVTT-HCC |
| 104 | Not yet recruiting | Extended-Duration Low-Dose Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism |
| 105 | Recruiting | Pilot Study: Comparison of Patients’ Knowledge of Direct Oral Anticoagulants Between 2 Cardiology Departments Offering or Not a Pharmaceutical Interview |
| 106 | Not yet recruiting | OsciPulse Device for the Prevention of VTE |
| 107 | Recruiting | Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD) |
| 108 | Recruiting | VTEval Project – Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE |
| 109 | Not yet recruiting | A Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay |
| 110 | Active, not recruiting | Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin |
| 111 | Recruiting | PET Fibrin Imaging of DVT and PE |
| 112 | Recruiting | A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism |
| 113 | Active, not recruiting | Returning Genome and Metabolome Data to FinTerveys 2017 Participants: P5.fi FinTerveys Study |
| 114 | Active, not recruiting | Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events |
| 115 | Not yet recruiting | Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study |
| 116 | Recruiting | Prevention and Prophylaxis of Cancer Associated Thrombosis in High Risk Oncology Patients |
| 117 | Recruiting | Pregnancy and Risk of Venous Thromboembolism |
| 118 | Recruiting | Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) |
| 119 | Not yet recruiting | Preoperative Subclinical DVT Screening in Locally Advanced Bladder Cancer Patients Candidate for Radical Cystectomy. |
| 120 | Not yet recruiting | A Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment |
| 121 | Active, not recruiting | Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial |
| 122 | Recruiting | Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 |
| 123 | Recruiting | Association of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients |
| 124 | Not yet recruiting | Continuous Heparin Infusion to Prevent Catheter-related Thrombosis |
| 125 | Recruiting | The Relationship Between the Lack of AT-Ⅲ, PC, PS Activity and PICC-related Thrombosis |
| 126 | Recruiting | Thrombotic Complications After Central Venous Catheterization |
| 127 | Active, not recruiting | Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center |
| 128 | Recruiting | Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurosurgical Intensive Care Unit |
| 129 | Recruiting | Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events |
| 130 | Not yet recruiting | HAVEN-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism |
| 131 | Not yet recruiting | Screening for Cancer in Patients With Thromboembolic Disease |
| 132 | Recruiting | Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients |
| 133 | Recruiting | Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians |
| 134 | Recruiting | Safety and Efficacy Study of Fitaya Vena Cava Filter |
| 135 | Recruiting | Perioperative Therapy for Hepatocellular Carcinoma |
| 136 | Active, not recruiting | A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics |
| 137 | Not yet recruiting | anti10a Levels in Women Treated With LMWH in the Postpartum Period |
| 138 | Recruiting | COVID-19, bLOod Coagulation and Thrombosis |
| 139 | Recruiting | Catheter Associated Asymptomatic Thrombosis in Intensive Care Unit |
| 140 | Active, not recruiting | Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia |
| 141 | Not yet recruiting | Non-Interruptive Alerts for Improving Use of Clinical Decision Rules |
| 142 | Not yet recruiting | HoloStream Study – Video Capture Device Usage |
| 143 | Active, not recruiting | Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS) |
| 144 | Recruiting | TenTaTorch: Venepuncture Made Easy |
| 145 | Not yet recruiting | CLiCK in the Intensive Care Unit |
| 146 | Recruiting | Incidence of Complications of Peripheral Venous Access in the Type 2 Diabetic Population |
| 147 | Recruiting | Ongoing Registry of Treatment of Venous Thromboembolism |
| 148 | Recruiting | COVID-19 Anticoagulation in Children – Thromboprophlaxis (COVAC-TP) Trial |
| 149 | Recruiting | Vienna Vascular Liver Disease Study |
| 150 | Enrolling by invitation | The Central Venous Catheter Related Complications in Critically Ill Patients |
| 151 | Recruiting | Blood Management During ECMO for Cardiac Support |
| 152 | Enrolling by invitation | JET Enhanced Thrombectomy Intervention |
| 153 | Recruiting | Point-of-care Ultrasound in Finland |
| 154 | Not yet recruiting | AntiCoagulation Tracking InterVention and Evaluation |
| 155 | Recruiting | Cardiovascular Complications and COVID-19 (CovCardioVasc-Study) |
| 156 | Recruiting | Improving Safety of Diagnosis and Therapy in the Inpatient Setting |
| 157 | Recruiting | A Prospective Study to Assess the Risk Factors That Contribute to Thrombosis in Patients With Lower Limb Injuries. |
| 158 | Active, not recruiting | Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys |
| 159 | Not yet recruiting | Pre- vs Postoperative Thromboprophylaxis for Liver Resection |
| 160 | Recruiting | Prospective Cohort Study for Varicose Veins Incidence and Natural Course |
| 161 | Recruiting | Midlines and Thrombophlebitis |
| 162 | Recruiting | Bern Venous Stent Registry |
| 163 | Recruiting | Screening for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism |
| 164 | Not yet recruiting | The MUFFIN-PTS Trial |
| 165 | Recruiting | Investigating the Involvement of ACE and Angiotensinogen Genes’ Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events |
| 166 | Not yet recruiting | Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports |
| 167 | Not yet recruiting | A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery |
| 168 | Recruiting | WHITE Study: WHIch Decision After a First Venous ThromboEmbolism? |
| 169 | Recruiting | Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection |
| 170 | Not yet recruiting | Study on Inferior Vena Cava Thrombosis |
| 171 | Not yet recruiting | Spontaneous Retinal Artery Pulses (SPARs) as a Prognostic Determinant of Central Retinal Vein Occlusions (CRVO) in Patients With or Without Intravitreal Aflibercept Injections |
| 172 | Not yet recruiting | Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment |
| 173 | Not yet recruiting | 601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO) |
| 174 | Not yet recruiting | 601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO) |
| 175 | Recruiting | Central Retinal Vein Occlusion (CRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only. |
| 176 | Not yet recruiting | Branch Retinal Vein Occlusion (BRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only. |
| 177 | Active, not recruiting | A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders |
| 178 | Active, not recruiting | Angioplasty-stenting vs Optimal Medical Treatment on Post-thrombotic Syndrome Reduction |
| 179 | Recruiting | Ultra-wide-field Fluorescein Angiography in Patients With Retinal Vein Occlusion |
| 180 | Recruiting | Treatment of Central Retinal Vein Occlusion Using Stem Cells Study |
| 181 | Active, not recruiting | Ultra-wide Fluorescein Angiography in Patients With Central Retinal Vein Occlusion Treated by Afilbercept |
| 182 | Recruiting | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients |
| 183 | Recruiting | Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents |
| 184 | Recruiting | Statins for Venous Event Reduction in Patients With Venous Thromboembolism |
| 185 | Recruiting | Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections |
| 186 | Not yet recruiting | Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice |
| 187 | Recruiting | Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole |
| 188 | Recruiting | Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole |
| 189 | Enrolling by invitation | Post Intravitreal Injection Topical NSAID vs. Patching |
| 190 | Active, not recruiting | Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO |
| 191 | Not yet recruiting | Anti-VEGF Instead of Intraoperative Fan-shaped Photocoagulation in BRVO Combined With Vitreous Hemorrhage |
| 192 | Recruiting | Study of the Retinal Vascularization by Laser Doppler Velocimetry Coupled With an Adaptive Optics Camera ( AO-LDV) |
| 193 | Active, not recruiting | OCT in Retinal Vein Occlusions |
| 194 | Active, not recruiting | Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) |
| 195 | Recruiting | A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion |
| 196 | Recruiting | A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion |
| 197 | Recruiting | A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) |
| 198 | Not yet recruiting | Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant – A Sustained, Low Dose Dexamethasone Therapy |
| 199 | Active, not recruiting | Continuing Assessment of Patients Treated With ranibizUmab for REtinal Vein Occlusion (CAPTURE) |
| 200 | Recruiting | Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections |
| 201 | Recruiting | Combination of Ranibizumab and Targeted Laser Photocoagulation |
| 202 | Recruiting | Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab |
| 203 | Recruiting | Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept |
| 204 | Recruiting | Assessment of Retinal Vessel Diameters and Red Blood Velocities in Patients With BRVO and Healthy Subjects |
| 205 | Recruiting | Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein Occlusion |
| 206 | Not yet recruiting | Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion |
| 207 | Recruiting | Long-term Outcome After Edoxaban Versus Vitamin K Antagonists for Acute VTE |
| 208 | Active, not recruiting | Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China |
| 209 | Active, not recruiting | Minocycline to Treat Branch Retinal Vein Occlusion |
| 210 | Recruiting | Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion |
| 211 | Recruiting | Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion |
| 212 | Recruiting | Influence of Systemic Parameters in Diabetic Macular Edema – LIPSIA Study |
| 213 | Recruiting | Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion |
| 214 | Active, not recruiting | Navigated Laser In Branch Retinal Vein Occlusion Study |
| 215 | Recruiting | Time Efficiency Comparison of Two IntraVitreal Injection Techniques |
| 216 | Recruiting | Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph |
| 217 | Recruiting | A Study to Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion, Which Either Have or Have Not Been Pretreated for Their Disease |
| 218 | Recruiting | Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease |
| 219 | Recruiting | High Resolution Retina Imaging |
| 220 | Not yet recruiting | Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study |
| 221 | Not yet recruiting | Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium |
| 222 | Active, not recruiting | Ocular Manifestations in Rheumatic Diseases |
| 223 | Recruiting | Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathies |
| 224 | Recruiting | SD-OCT Angiography |
| 225 | Active, not recruiting | Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study |
| 226 | Recruiting | National Eye Institute Biorepository for Retinal Diseases |
| 227 | Recruiting | Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome |
| 228 | Recruiting | Phase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced Hepatocellular Carcinoma |
| 229 | Recruiting | PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST) |
| 230 | Active, not recruiting | Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma |
| 231 | Not yet recruiting | COVID-19 And Geko Evaluation: The CAGE Study |
| 232 | Recruiting | Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19 |
| 233 | Recruiting | Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test. |
| 234 | Recruiting | Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants |
| 235 | Recruiting | Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity |
| 236 | Active, not recruiting | Thrombosis Outcomes in Pediatric Venous Thromboembolism |
| 237 | Recruiting | Caprini Score in Venous Surgery: a Prospective Cohort Study |
| 238 | Recruiting | Venous Thromboembolism in Myotonic Dystrophy Type 1 |
| 239 | Recruiting | PREVENTion of Clot in Orthopaedic Trauma |
| 240 | Recruiting | Ultrasound Elastography Assessment of Spleen and Liver Stiffness Before and After Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedure |
| 241 | Recruiting | Donor Specific HLA Alloantibodies in Liver Transplantation |
